Orocal D3


Indications and Reactions:

Role Indications Reactions
Secondary
Hypopituitarism 16.9%
Rheumatoid Arthritis 16.9%
Heart Transplant 12.7%
Insomnia 8.5%
Hypertension 7.0%
Product Used For Unknown Indication 7.0%
Osteoporosis 5.6%
Breast Cancer 4.2%
Depression 4.2%
Hypertriglyceridaemia 4.2%
Osteopenia 4.2%
Benign Prostatic Hyperplasia 2.8%
Bronchitis 1.4%
Colitis Ulcerative 1.4%
Lumbar Puncture 1.4%
Rhinitis Allergic 1.4%
Post Herpetic Neuralgia 8.7%
Radiculopathy 8.7%
Viral Infection 8.7%
Colitis Microscopic 4.3%
Fall 4.3%
Gingival Bleeding 4.3%
Haemoglobin Decreased 4.3%
Hypercalcaemia 4.3%
Hypercholesterolaemia 4.3%
Meningitis 4.3%
Middle Insomnia 4.3%
Nephrolithiasis 4.3%
Neuropathy Peripheral 4.3%
Osteopenia 4.3%
Pancreatitis 4.3%
Pancreatitis Acute 4.3%
Pharyngitis 4.3%
Renal Failure 4.3%
Skin Lesion 4.3%
Varicose Vein 4.3%
Concomitant
Drug Use For Unknown Indication 20.5%
Product Used For Unknown Indication 18.6%
Rheumatoid Arthritis 11.4%
Osteoporosis 10.2%
Hypertension 6.8%
Crohn's Disease 5.0%
Pain 3.9%
Chronic Graft Versus Host Disease 3.1%
Hiv Infection 2.7%
Depression 2.3%
Anxiety 2.1%
Diabetes Mellitus 1.9%
Prophylaxis 1.7%
Lymphoma 1.6%
Deep Vein Thrombosis 1.5%
Diarrhoea 1.5%
Polyarthritis 1.5%
Type 2 Diabetes Mellitus 1.5%
Unevaluable Event 1.3%
Hepatitis B 1.2%
Small Intestinal Stenosis 9.1%
Vomiting 9.1%
Pancytopenia 6.8%
Pyrexia 6.8%
Renal Failure 6.8%
Somnolence 5.7%
Vertigo 5.7%
Weight Decreased 5.7%
Fall 4.5%
Thrombocytopenia 4.5%
Thrombotic Thrombocytopenic Purpura 4.5%
Aspartate Aminotransferase Increased 3.4%
Back Pain 3.4%
Hallucination 3.4%
Off Label Use 3.4%
Pain In Extremity 3.4%
Rash Pustular 3.4%
Renal Failure Acute 3.4%
Renal Haematoma 3.4%
Rhonchi 3.4%

Drug Data